macs monthly header with macs logo and graphic of medical professionals in training

The latest in substance use disorders and pain management education for healthcare providers

November 2024

Dear Anna,


During National Nurse Practitioner Week (November 10 – 16), MACS is celebrating the vital role of the 385,000+ nurse practitioners (NPs) nationwide who deliver patient-centered care in hospitals, emergency departments, urgent care centers, nursing homes and private practices. As primary care providers, NPs play a crucial part in addressing substance use disorder, often serving as the initial point of contact for patients seeking treatment. MACS is proud to support these dedicated healthcare professionals in their efforts to combat substance use disorder and manage chronic pain for their patients, offering expertise and resources to enhance their life-changing work.


November is also National Hospice and Palliative Care Month, highlighting the intersectionality of the overdose epidemic and revealing the needs of individuals across all stages of life. Approximately 20% of adults 65 and over will experience mental health conditions, but despite these needs, less than 50% of older adults with mental health conditions and/or substance use disorders receive treatment (1). A growing body of research also suggests that substance use and related harms are becoming more prevalent for older adults compared to younger, including cigarette smoking and fatal opioid overdose rates (2, 3).


In late September, MACS attended the Hospice & Palliative Care Network of Maryland Annual Conference. In addition to members of our team sharing resources about how MACS supports providers working in hospice and palliative care programs, MACS Consultant Michael Fingerhood, MD, delivered a presentation on Benzodiazepine Use in the Older Adult Population.


Finally, in addressing the evolving landscape of substance use disorders, MACS is pleased to share a valuable resource with healthcare providers in Maryland. Our Xylazine and Opioid Use Fact Sheet provides critical information on the prevalence, characteristics and harms associated with xylazine, as well as essential resources to support patients affected by its use. This comprehensive guide aims to enhance healthcare professionals' understanding and response to the challenges posed by xylazine and opioid use in our communities. In addition, through Maryland's Office of Overdose Response, the Maryland Department of Health continues to address xylazine use through resources to providers and equips them with information needed to keep their patients safe.


Explore this newsletter and the tools available on the MACS website for additional information about provider education and treatment resources.


The MACS Team


1. Committee on the Mental Health Workforce for Geriatric P, Board on Health Care S, Institute of M. In: Eden J, Maslow K, Le M, Blazer D, eds. The Mental Health and Substance Use Workforce for Older Adults: In Whose Hands? National Academies Press (US)

2. Kleykamp BA, Kulak JA. Cigarette Use Among Older Adults: A Forgotten Population. Am J Public Health. Jan 2023;113(1):27-29. doi:10.2105/ajph.2022.307151

3. Kariisa M, Davis NL, Kumar S, et al. Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics—25 states and the District of Columbia, 2019–2020. Morbidity and Mortality Weekly Report. 2022;71(29):940. 

PRESCRIBER SURVEY: Participation requested

As part of an ongoing effort to understand the landscape of buprenorphine access, MACS is surveying prescribers across Maryland.


We would greatly appreciate your assistance with this effort by taking a few moments to complete our voluntary survey, which can be accessed online using the link below. In addition, please feel free to share the survey with your own network.

Complete the survey

EDUCATION

Upcoming MACS Training Opportunities

MACS Webinar

Alcohol Use Disorder Review, Co-Occurring Disorders, and Pharmacologic Treatments/Pitfalls


Friday, December 13 | 12:00 p.m. – 1:00 p.m.


Presented by MACS Consultant Avinash Ramprashad, MD

Register

MACS for MOMs Webinar

PCSS-MOUD Half and Half Training Hosted by MACS for MOMs


Friday, January 10 | 8:00 a.m. 12:00 p.m.


Presented by MACS for MOMs Medical Director Christopher Welsh, MD, and Consultant Katrina Mark, MD

Register

MACS Webinar

Decreasing Treatment Disparities for African Americans With OUD


Friday, January 31 | 12:00 p.m. 1:00 p.m.


Presented by Aliya Jones, MD, Executive Medical Director of Behavioral Health for Luminis Health


Save the date! Registration link coming soon.

Upcoming Trainings of Interest

Yale Program in Addiction Medicine

Addiction Medicine Grand Rounds: Incorporating Social Justice Principles into Substance Use Research, Treatment, and Prevention


Tuesday, November 12 | 12:00 p.m. – 1:00 p.m.

Register

Grayken Center for Addiction Training & TA

Addiction 101


Thursday, November 21 | 9:00 a.m. – 10:00 a.m.

Register

MACS ECHO Clinics

Join our learning communities for continuous case-based discussions and didactic presentations linking expert specialist teams with healthcare providers and their practices. MACS ECHO Clinics count toward the required 8-hours of SUD training for DEA license renewal or registration.

Opioid Treatment Program ECHO

ADHD and OUD


Devang Gandhi, MD


Wednesday, November 6

12:30 p.m. – 1:30 p.m.

Register

Maternal Health ECHO

SUD and Child Development


Kathleen Connors, MSW, LCSW-C


Tuesday, November 12

8:00 a.m. 9:00 a.m.

Register

Substance Use Disorders ECHO

Optimizing the Pharmacy Partnership in Managing Patients with OUD


Bethany DiPaula, PharmD


Wednesday, November 20

12:30 p.m. – 1:30 p.m.

Register

Providing MOUD from a Trauma-Informed Perspective

Trauma-Informed Care for LGBTQIA+ Populations


Lee Westgate, MSW, LCSW-C


Thursday, November 21

12:00 p.m. 1:00 p.m.

Register

CONFERENCES AND EVENTS

Maryland Rural Health Association Annual Conference 

Sunday, November 3 – Tuesday, November 5

Crowne Plaza Annapolis | Annapolis, Maryland

MACS exhibit table


Sigma Theta Tau International Honor Society of Nursing Annual Substance Use Disorder Conference 

Wednesday, November 13 | 5:00 p.m. – 9:00 p.m.

TidalHealth Peninsula Regional | Salisbury, Maryland (Virtual attendance available)

Naloxone to the Rescue: Update on Community Efforts to Combat Overdose 

Presentation by MACS Consultant Bethany DiPaula, PharmD


2024 Annual Medication Safety Conference

Friday, November 15 | 12:00 p.m. – 4:30 p.m.

Virtual Conference

MACS exhibiting remotely


Nurse Practitioner Association of Maryland Fall Conference

Saturday, November 16

Howard Community College | Columbia, Maryland

MACS exhibit table

NEWS

Layperson-Administered Naloxone Trends Reported in Emergency Medical Service Activations, 2020-2022


To assess layperson-administered naloxone trends between 2020 and 2022, researchers conducted a retrospective cross-sectional study among 65,621,195 emergency medical services (EMS) activations from 911 responses within this time period, excluding activations within health care settings and interfacility/medical transports. EMS clinician documentation found that while EMS-administered naloxone decreased by 6.1% within the study's time period, the rate of layperson-administered naloxone increased by 43.5%. Researchers consider this study demonstrative of the impact of take-home naloxone initiatives and the utility of EMS data.


Read more...

Alcohol Use as a Predictor of Intimate Partner Violence in Emerging Adulthood: A Dyadic Daily Diary Investigation


This convenience sample study, which pulled from alcohol using college-student couples at a Midwestern university in the United States, utilized a 60-day daily diary survey to assess whether alcohol use by both members of a relationship dyad would increase the odds of intimate partner violence (IPV) compared to alcohol use by one or no dyad members. With daily surveys asking participants about the prior day's alcohol use and IPV perpetration and victimization, results found that the odds of psychological IPV perpetration and physical IPV victimization were higher when both partners were drinking relative to one partner drinking.


Read more...

Incidence of Hospitalizations Involving Alcohol Withdrawal Syndrome in a Primary Care Population


In this cohort study, researchers sought to examine how often primary care patients in an integrated health system experience hospitalizations involving alcohol withdrawal syndrome (AWS). Using electronic health records and insurance claims of 544,825 adults, the study yielded findings showing AWS hospitalizations were especially common in male patients between 30 to 49 years old and individuals presenting a high-risk alcohol screening. In patients younger than 60 years old, AWS was as common or more common than complications stemming from other chronic conditions (e.g., diabetes and hypertension).


Read more...

Cannabis and hallucinogen use remained at historic highs in 2023


This news release summarizes the latest survey results from Monitoring the Future, which is an ongoing study of the attitudes and behaviors of Americans from adolescence to adulthood. Findings from 2023 suggest that past-year use of cannabis and hallucinogens remained at historically high levels among adults aged 19 to 30 and 35 to 50. When accounting for trends between sexes, 19- to 30-year-old female respondents reported – for the first time – a higher prevalence of past-year cannabis use than their male counterparts. Among adults participating in the study, alcohol continues to be the most used substance reported. Those aged 35 to 50 reported a greater prevalence of binge drinking in 2023 than from five and 10 years ago. However, past-month and daily alcohol use, along with binge drinking, continued to decline among 19- to 30-year-olds.


Read more...

Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder


A cohort study of 33,006 individuals with opioid use disorder (OUD) and type 2 diabetes (T2D) built upon anecdotal reports of reduced drug cravings in individuals using semaglutide and empirical studies showing its therapeutic benefit to those with alcohol and nicotine use disorders. By observing health records from December 2017 to June 2023, researchers found that semaglutide was associated with a lower risk of opioid overdose during a 1-year follow-up from first prescription when compared with other antidiabetic medications.


Read more...

Holidays

MACS Phone Line Will Be Closed

November 5 – Election Day

November 11 – Veterans Day

November 28 – Thanksgiving

November 29 – Native American Heritage Day

December 25 – Christmas

January 1 – New Year's Day

November Observances

National Hospice and Palliative Care Month

National Nurse Practitioner Week

November 10 – 16

National Rural Health Day

November 21

Follow us to stay connected:

Facebook  LinkedIn  X  Instagram  YouTube

RESOURCES

Listening Session: Use of High Dose Buprenorphine for the Treatment of Opioid Use Disorder (SAMHSA)

MACS Fact Sheet: Xylazine and Opioid Use

JAMA Patient Page: Cannabinoid Hyperemesis Syndrome

National Nurse Practitioner Week Resource Guide

X Share
LinkedIn Share

Follow us:

Facebook  X  LinkedIn  Instagram  YouTube